Literature DB >> 2493305

Life threatening interaction between tamoxifen and warfarin.

P Tenni1, D L Lalich, M J Byrne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2493305      PMCID： PMC1835395          DOI： 10.1136/bmj.298.6666.93

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Life threatening interaction between tamoxifen and warfarin.

Authors:  R Lodwick; B McConkey; A M Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

Review 2.  The pharmacology and clinical uses of tamoxifen.

Authors:  B J Furr; V C Jordan
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

3.  Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

Authors:  E Coezy; J L Borgna; H Rochefort
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

Review 4.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

5.  Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer.

Authors:  C Fabian; L Tilzer; L Sternson
Journal:  Biopharm Drug Dispos       Date:  1981 Oct-Dec       Impact factor: 1.627
  5 in total
  13 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

3.  Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file.

Authors:  L D Ritchie; S M Grant
Journal:  BMJ       Date:  1989-05-06

Review 4.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.

Authors:  R A Yates; J Wong; M Seiberling; M Merz; W März; M Nauck
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

Review 6.  Pharmacokinetics of selective estrogen receptor modulators.

Authors:  Karla C Morello; Gregory T Wurz; Michael W DeGregorio
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 8.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

9.  Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.

Authors:  L K Webster; A G Ellis; J F Bishop
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 10.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.